NOTE:    The following Minutes are provided for informational purposes only.

If you would like to obtain an official copy of these Minutes, please contact the

State Board of Pharmacy at 614/466-4143 for instructions and fee.

 

 

 

Minutes Of The Meeting

Ohio State Board of Pharmacy

August 5, 6, 7, 2002

 

MONDAY, AUGUST 5, 2002

 

10:00 a.m.

ROLL CALL

 

 

The State Board of Pharmacy convened in Room East-B, 31st Floor, Vern Riffe Center for Government and the Arts, 77 South High Street, Columbus, Ohio with the following members present:

 

 

Diane C. Adelman, R.Ph. (President); Robert P. Giacalone, R.Ph. (Vice-President); Suzanne R. Eastman, R.Ph.; Elizabeth I. Gregg, R.Ph.; Lawrence J. Kost, R.Ph.; Nathan S. Lipsyc, R.Ph.; Dorothy S. Teater, Public Mem­ber; and James E. Turner, R.Ph.

 

 

Also present were William T. Winsley, Executive Director; Timothy Benedict, Assistant Executive Director; William McMillen, Licensing Administrator; Mark Keeley, Legislative Affairs Administrator; David Rowland, Legal Affairs Administrator; Robert Cole, Compli­ance Supervisor; and Sally Ann Steuk, Assistant Attorney General.

 

R-2003-011

After a discussion of information received regarding the NABP/AACP District IV meeting to be held October 4-6, 2002 in Grand Rapids, Michigan, Mr. Turner moved that the Board authorize Mrs. Adelman and Mr. Winsley to attend the meeting, that their expenses be paid by the Board, and that the time spent at the meeting be considered as time worked.  The motion was seconded by Mrs. Teater and approved by the Board (Aye-7/Nay-0).

 

10:05 a.m.

Mrs. Gregg moved that the Board go into Executive Session for the purpose of the investi­gation of complaints regarding licensees and registrants pursuant to Section 121.22(G)(1) of the Revised Code and for the purpose of conferring with an attorney for the Board regarding pending or imminent court action pursuant to Section 121.22(G)(3) of the Re­vised Code.  The motion was seconded by Mr. Lipsyc and a roll call vote was conducted by President Adelman as follows: Eastman-Yes, Giacalone-Yes, Gregg-Yes, Kost-Yes, Lipsyc-Yes, Teater-Yes, and Turner-Yes.

 

10:06 a.m.

Gregory Braylock, R.Ph. arrived and joined the Executive Session in progress.

 

11:35 a.m.

The Executive Session ended and the meeting was opened to the public.

 

R-2003-012

Mr. Giacalone moved that, pursuant to Section 3719.121 of the Revised Code, the Board summarily suspend the license to practice pharmacy belonging to Matthew Nourse, R.Ph. (03-1-22575) due to the fact that a continuation of his professional practice presents a danger of immediate and serious harm to others.  The motion was seconded by Ms. Eastman and approved by the Board (Aye-8/Nay-0).

 

R-2003-013

Mr. Giacalone then moved that the Board accept the settlement offer as revised by the Board received in the matter of Richard Ridzon, R.Ph.  The motion was seconded by Mr. Kost and approved by the Board (Aye-8/Nay-0).

 

R-2003-014

Ms. Eastman then moved that the Board deny the settlement offer from Joseph Cusma, R.Ph.  The motion was seconded by Mr. Kost and approved by the Board (Aye-8/Nay-0).

 

R-2003-015

After reviewing the documentation submitted on behalf of Michele Midlick, R.Ph., the consensus of the Board was that she has not yet complied with the requirements of her Board order.

 

11:48 a.m.

The meeting was recessed for lunch.

 

12:55 p.m.

The meeting resumed in Room East-B, 31st Floor, Vern Riffe Center for Government and the Arts with all members present.

 

  1:04 p.m.

Mr. Lipsyc moved that the Board go into Executive Session for the purpose of the investi­gation of complaints regarding licensees and registrants pursuant to Section 121.22(G)(1) of the Revised Code.  The motion was seconded by Mrs. Gregg and a roll call vote was conducted by President Adelman as follows: Braylock-Yes, Eastman-Yes, Giacalone-Yes, Gregg-Yes, Kost-Yes, Lipsyc-Yes, Teater-Yes, and Turner-Yes.

 

  1:14 p.m.

R-2003-016

The Executive Session ended and the meeting was opened to the public.  Mr. Braylock moved that the Board deny the settlement offer received in the matter of Charles Willson, R.Ph. and that the hearing be held as scheduled.  The motion was seconded by Mr. Turner and approved by the Board (Aye-8/Nay-0).

 

  1:15 p.m.

The Board took a brief recess.

 

  1:30 p.m.

The Board was joined by Assistant Attorney General Sally Ann Steuk for the purpose of conducting an adjudication hearing in accordance with Ohio Revised Code Chapters 119. and 4729. in the matter of Charles R. Willson, R.Ph., Berlin Center.

 

  6:44 p.m.

The hearing ended and the record was closed.

 

  6:45 p.m.

Mrs. Gregg moved that the Board go into Executive Session for the purpose of the investi­gation of complaints regarding licensees and registrants pursuant to Section 121.22(G)(1) of the Revised Code.  The motion was seconded by Mr. Braylock and a roll call vote was conducted by President Adelman as follows: Braylock-Yes, Giacalone-Yes, Gregg-Yes, Eastman-Yes, Lipsyc-Yes, Kost-Yes, Teater-Yes, and Turner-Yes.

 

  7:35 p.m.

R-2003-017

The Executive Session ended and the meeting opened to the public.  Mr. Braylock moved that the Board adopt the following Order in the matter of Charles R. Willson, R.Ph.:

 

 

ORDER OF THE STATE BOARD OF PHARMACY

(Docket No. D-010313-047)

 

In The Matter Of:

 

CHARLES R. WILLSON, R.Ph.

13804 Leffingwell Road

Berlin Center, Ohio  44401

(R.Ph. No. 03-3-15794)

 

 

INTRODUCTION

 

THE MATTER OF CHARLES R. WILLSON CAME FOR HEARING ON AUGUST 5, 2002, BEFORE THE FOLLOWING MEMBERS OF THE BOARD: DIANE C. ADELMAN, R.Ph. (presiding); GREGORY BRAYLOCK, R.Ph.; SUZANNE R. EASTMAN, R.Ph.; ROBERT P. GIACALONE, R.Ph.; ELIZABETH I. GREGG, R.Ph.; LAWRENCE J. KOST, R.Ph.; NATHAN S. LIPSYC, R.Ph.; DOROTHY S. TEATER, PUBLIC MEMBER; AND JAMES E. TURNER, R.Ph.

 

 

CHARLES R. WILLSON WAS REPRESENTED BY DAVID W. GRAUER AND THE STATE OF OHIO WAS REPRESENTED BY SALLY ANN STEUK, ASSISTANT ATTORNEY GENERAL.

 

 

SUMMARY OF EVIDENCE

State's Witnesses

1.  David Gallagher, Ohio State Board of Pharmacy

2.  Timothy J. Benedict, R.Ph., Ohio State Board of Pharmacy

 

Respondent's Witnesses

1.  Charles R. Willson, R.Ph., Respondent

 

 

State's Exhibits

1.  Copy of Summary Suspension Order/Notice of Opportunity for Hearing  [03-13-01]

1A-1D.  Procedurals

1E.  Copy of Addendum Notice  [08-16-01]

1F-1H.  Procedurals

1I.  Copy of Amendment Notice  [09 20-01]

1J-1Q.  Procedurals

1R.  Copy of Addendum Notice  [07-09-02]

2.  Statement of Michael H. Linhart, R.Ph.  [03-08-01]

3.  Rx 156572

4.  Statement of Nick E. Sucaciu  [04-12-01]

5.  Rite Aid #3167 C-II Perpetual Inventory Form - OxyContin 40mg  [02-17-98 to 03-10-01]

6.  Drug Audit Accountability Sheet for Adderall 10mg at Rite Aid #3167  [04-02-01]

7.  Drug Audit Accountability Sheet for Concerta 36mg at Rite Aid #3167  [04-02-01]

8.  Drug Audit Accountability Sheet for OxyContin 10mg at Rite Aid #3167  [04-02-01]

9.  Drug Audit Accountability Sheet for OxyContin 20mg at Rite Aid #3167  [04-02-01]

 

10.  Drug Audit Accountability Sheet for OxyContin 40mg at Rite Aid #3167  [04-02-01]

11.  Drug Audit Accountability Sheet for Oxycodone/Apap 5/500mg at Rite Aid #3167  [04-02-01]

12.  Drug Audit Accountability Sheet for Oxycodone/Apap 5/325mg at Rite Aid #3167  [04-02-01]

13.  Drug Audit Accountability Sheet for Phentermine 30mg at Rite Aid #3167  [04-02-01]

14.  Drug Audit Accountability Sheet for Phentermine 37.5mg at Rite Aid #3167  [04-02-01]

15.  Drug Audit Accountability Sheet for Vicoprofen 7.5/200mg at Rite Aid #3167  [04-02-01]

16.  Drug Audit Accountability Sheet for Alprazolam .25mg at Rite Aid #3167  [04-02-01]

17.  Drug Audit Accountability Sheet for Alprazolam .5mg at Rite Aid #3167  [04-02-01]

18.  Drug Audit Accountability Sheet for Alprazolam 1mg at Rite Aid #3167  [04-02-01]

19.  Drug Audit Accountability Sheet for Alprazolam 2mg at Rite Aid #3167  [04-02-01]

20.  Drug Audit Accountability Sheet for Lorazepam 1mg at Rite Aid #3167  [04-02-01]

21.  Drug Audit Accountability Sheet for Lorazepam 2mg at Rite Aid #3167  [04-02-01]

22.  Drug Audit Accountability Sheet for Diazepam 2mg at Rite Aid #3167  [04-02-01]

23.  Drug Audit Accountability Sheet for Diazepam 5mg at Rite Aid #3167  [04-02-01]

24.  Drug Audit Accountability Sheet for Diazepam 10mg at Rite Aid #3167  [04-02-01]

25.  Drug Audit Accountability Sheet for Temazepam 15mg at Rite Aid #3167  [04-02-01]

26.  Drug Audit Accountability Sheet for Temazepam 30mg at Rite Aid #3167  [04-02-01]

27.  Drug Audit Accountability Sheet for Oxazepam 10mg at Rite Aid #3167  [04-02-01]

28.  Drug Audit Accountability Sheet for Oxazepam 15mg at Rite Aid #3167  [04-02-01]

29.  Drug Audit Accountability Sheet for Meprobamate 200mg at Rite Aid #3167  [04-02-01]

30.  Drug Audit Accountability Sheet for Meprobamate 400mg at Rite Aid #3167  [04-02-01]

31.  Rite Aid Customer History Report for Patient #8  [01-01-98 to 04-30-01]

31A.  Therapy Days/Calendar Days Comparison Report for Patient #8  [03-21-99 to 03-22-00]

32.  Rx 172456

33.  Rx 174620

 

34.  Statement of Dr. Diglisic Gordana  [02-23-01]

35.  Rite Aid Customer History Report for Patient #1  [01-01-99 to 04-25-01]

35A.  Therapy Days/Calendar Days Comparison Report for Patient #1  [01-04-99 to 02-12-01]

36.  Rx 107902

37.  Rx 108995

38.  Rx 109647

39.  Rx 110304

40.  Rx 110945

 

41.  Rx 111648

42.  Rx 112443

43.  Rx 113221

44.  Rx 115411

45.  Rx 116586

46.  Rx 117183

47.  Rx 117881

48.  Rx 118476

49.  Rx 119014

50.  Rx 120178

51.  Rx 120766

52.  Rx 121284

53.  Rx 121847

54.  Rx 122384

55.  Rx 122912

56.  Rx 123454

57.  Rx 123680

58.  Rx 124375

59.  Rx 124890

60.  Rx 125603

61.  Rx 126031

62.  Rx 127050

63.  Rx 127898

64.  Rx 129044

65.  Rx 129708

 

66.  Rx 130313

67.  Rx 131561

68.  Rx 133942

69.  Rx 134576

70.  Rx 135215

71.  Rx 135672

72.  Rx 136246

73.  Rx 136822

74.  Rx 137475

75.  Rx 138758

76.  Rx 140060

77.  Rx 140297

78.  Rx 140918

79.  Rx 141326

80.  Rx 141327

81.  Rx 141932

82.  Rx 142558

83.  Rx 143202

84.  Rx 143748

85.  Rx 144434

86.  Rx 145054

87.  Rx 145705

88.  Rx 146410

89.  Rx 147080

90.  Rx 147696

 

91.  Rx 148247

92.  Rx 148526

93.  Rx 148837

94.  Rx 149416

95.  Rx 149415

96.  Rx 150003

97.  Rx 150575

98.  Rx 151107

99.  Rx 151799

100.  Rx 152147

101.  Rx 152760

102.  Rx 153274

103.  Rx 154357

104.  Rx 154829

 

105.  Rx 155372

106.  Rx 158749

107.  Rx 159782

108.  Rx 160384

109.  Rx 161081

110.  Rx 162954

111.  Rx 163571

112.  Rx 164728

113.  Rx 165417

114.  Rx 166126

115.  Rx 166604

116.  Rx 167309

117.  Rx 167965

118.  Rx 168630

119.  Rx 169579

 

120.  Rx 172315

121.  Rx 172700

122.  Rite Aid Printout of Rx 173520  [06-27-01]

123.  Rx 174258

124.  Rite Aid Customer History Report for Patient #2  [01-01-95 to 04-09-01]

124A.  Therapy Days/Calendar Days Comparison Report for Patient #2  [12-28-98 to 04-28-00]

125.  Rx 107486  [12-28-98]

126.  Rx 107486 and Rx 108841  [01-15-99]

127.  Rx 110753  [02-05-99]

128.  Rx 110753  [02-24-99]

129.  Rx 114580  [03-12-99]

130.  Rx 114580  [03-12-99] and Rx 116157  [03-30-99]

131.  Rx 117992  [04-20-99] and Rite Aid Printout of Rx 116157  [03-30-99]

132.  Rx 117992  [05-08-99]

133.  Rx 117992  [05-27-99]

134.  Rx 126066, Rx 126067, and Rx 126068  [08-04-99]

135.  Rx 126067  [08-22-99]

136.  Rx 126066 and Rx 126067  [09-08-99]

137.  Rx 130697

138.  Rx 132971  [10-26-99] and Rite Aid Printout of Rx 130697  [09-30-99]

139.  Rx 132971  [11-16-99]

140.  Rx 136169  [12-04-99]

141.  Rx 136169  [12-22-99]

142.  Rx 139260  [01-07-00]

143.  Rx 139260, Rx 136884, Rx 136111, Rx 136110, Rx 141147, and Rx 141146  [01-28-00]

144.  Rx 139260  [02-14-00]

145.  Rx 144806  [03-09-00]

146.  Rx 144806, Rx 138424, Rx 142192, and Rx 142193  [04-01-00]

 

147.  Rx 149280, Rx 149281, and Rx 149282  [04-28-00]148.  Rite Aid Customer History Report for Patient #3  [01-01-99 to 04-24-01]

148A.  Therapy Days/Calendar Days Comparison Report for Patient #3  [03-02-99 to 10-08-99]

149.  Rx 115068  [03-18-99]

150.  Rx 115068, Rx 116760, and Rx 116761  [04-06-99]

151.  Rx 115068  [04-16-99]

152.  Rx 117850

 

153.  Rx 113313  [03-02-99]

154.  Rx 113313, Rx 113312, Rx 109765, and Rx 108434  [04-01-99]

155.  Rx 117852

156.  Rx 118466  [04-26-99]

157.  Rx 118466  [04-30-99]

158.  Rx 119036 and 119037  [05-03-99]

159.  Rx 119976

160.  Rx 119036  [05-18-99]

161.  Rx 119036, Rx 109765, Rx 116340, and Rx 109473  [06-16-99]

162.  Rx 119036, Rx 119037, and Rx 116513  [07-02-99]

163.  Rx 119036  [07-17-99]

 

164.  Rx 125963  [08-02-99]

165.  Rx 125963  [08-19-99]

166.  Rx 125963  [08-27-99]

167.  Rx 127996  [08-31-99]

168.  Rx 127996  [09-13-99]

169.  Rx 129685

170.  Rx 131447

171.  Rite Aid Customer History Report for Patient #4  [01-01-95 to 03-08-01]

171A.  Therapy Days/Calendar Days Comparison Report for Patient #4  [02-12-98 to 12-06-98]

172.  Rite Aid Printout of Rx 82946  [02-12-98]

173.  Rx 84341

174.  Rx 86049

175.  Rx 87555

176.  Rx 89483

177.  Rx 91136  [06-05-98]

178.  Rx 91136  [07-05-98]

179.  Rx 94234

180.  Rx 95990

181.  Rite Aid Printout of Rx 98345

182.  Rx 99663  [09-28-98]

183.  Rx 99663  [10-12-98]

184.  Rx 101837

185.  Rx 103319

186.  Rx 103697

187.  Rx 104432  [11-20-98]

188.  Rx 105076

189.  Rx 104432  [12-04-98]

190.  Rx 104432  [12-06-98]

191.  Rx 84342

192.  Rx 84681

193.  Rx 85607

194.  Rx 85671

195.  Rx 86048

196.  Rx 87336

197.  Rx 87556

198.  Rx 88253

199.  Rx 97257

200.  Rx 98496

 

201.  Rite Aid Printout of Rx 100689

202.  Rx 102062

203.  Rx 102546

204.  Rx 103038

205.  Rx 103803

206.  Rite Aid Printout of Rx 104766

207.  Rite Aid Customer History Report for Patient #5  [01-01-99 to 04-25-01]

207A.  Therapy Days/Calendar Days Comparison Report for Patient #5  [07-07-99 to 02-10-01]

208.  Rx 124089  [07-07-99]

209.  Rx 124089  [07-12-99]210.  Rx 125089  [07-21-99]

211.  Rite Aid Printout of Rx 125089  [07-27-99]

212.  Rx 124089 and Rx 124090 [08-01-99]

213.  Rx 124089  [08-03-99]

214.  Rx 124089  [08-19-99]

215.  Rx 124089  [09-03-99]

 

216.  Rx 129875  [09-21-99]

217.  Rx 129875 and Rx 129873  [09-24-99]

218.  Rx 139324  [01-08-00]

219.  Rx 139324  [01-12-00]

220.  Rx 139324  [01-27-00]

221.  Rx 139324 and Rx 141487  [02-01-00]

222.  Rx 141487  [02-11-00]

223.  Rx 141487  [03-01-00]

 

224.  Rx 145317 and Rx 145318  [03-15-00]

225.  Rx 145317  [03-24-00]

226.  Rx 145317  [03-31-00]

227.  Rx 145317  [04-09-00]

228.  Rx 145317 and Rx 146839  [04-12-00]

229.  Rx 149465  [05-01-00]

230.  Rx 149465  [05-10-00]

231.  Rx 151803

232.  Rx 152940  [06-12-00] and Rx 152417  [06-14-00]

233.  Rx 152940 and Rx 152417  [06-22-00]

234.  Rx 154989  [07-11-00]

235.  Rx 154989 and Rx 154987  [07-18-00]

236.  Rx 154989 and Rx 154987  [07-21-00]

237.  Rx 154989  [07-24-00]

238.  Rx 168024

239.  Rx 168627  [12-18-00]

240.  Rx 168627  [12-24-00]

241.  Rx 168627 and Rx 168626  [12-26-00]

242.  Rx 168627  [12-28-00]

243.  Rx 171917

244.  Rx 173117 and Rx 171918  [02-01-01]

245.  Rx 173117  [02-06-01]

246.  Rx 173117 and Rx 171918  [02-10-01]

247.  Rx 165203  [11-10-00]

248.  Rx 165203  [11-13-00]

249.  Rx 165203  [11-25-00]

250.  Rx 168031

251.  Rx 168626  [12-18-00]

252.  Rx 168626  [12-24-00]

253.  Rx 168626  [12-26-00]

254.  Rx 169313  [12-28-00]

255.  Rx 169313  [01-02-01]

256.  Rx 169313  [01-05-01]

256A.  Rx 169313  [01-05-01]

257.  Rx 169313  [01-08-01]

 

258.  Rx 171918  [01-22-01]

260.  Rx 171918  [02-06-01]

262.  Rite Aid Customer History Report for Patient #6  [01-01-99 to 04-25-01]

262A.  Therapy Days/Calendar Days Comparison Report for Patient #6  [10-12-00 to 02-14-01]

263.  Rx 162657  [10-12-00]

264.  Rx 162657  [10-26-00]

265.  Rx 164636  [11-04-00]

266.  Rx 164636  [11-16-00]

267.  Rx 164636  [11-24-00]

268.  Rx 164636  [11-28-00]

269.  Rx 168029  [12-04-00]

269A.  Rx 164636  [12-04-00]

270.  Rx 168029  [12-18-00]

271.  Rx 169847

272.  Rx 170672  [01-09-01]

273.  Rx 170672  [01-14-01]

 

274.  Rx 172204  [01-24-01]

275.  Rx 172204  [02-01-01]

276.  Rx 172204  [02-07-01]

277.  Rx 172204  [02-14-01]

278.  Rite Aid Customer History Report for Patient #7  [06-01-98 to 03-01-01]

278A.  Therapy Days/Calendar Days Comparison Report for Patient #7  [10-14-99 to 01-03-00]

279.  Rx 131917  [10-14-99]

280.  Rx 131917  [[10-16-99]

281.  Rx 131917  [10-21-99]

282.  Rx 131917  [10-25-99]

283.  Rx 131917  [10-29-99]

 

284.  Rx 133467  [11-01-99]

285.  Rx 133467  [11-03-99]

286.  Rx 133903  [11-07-99]

287.  Rx 133903  [11-08-99]

288.  Rx 133903  [11-12-99]

289.  Rx 134374

290.  Rx 135183  [11-21-99]

291.  Rx 135183  [11-26-99]

292.  Rx 135183  [11-28-99]

293.  Rx 135183 and Rx 136242  [12-06-99]

294.  Rx 136590

295.  Rx 135183 and Rx 137182  [12-16-99]

296.  Rx 138182  [12-27-99]

297.  Rx 138182  [12-28-99]

298.  Rx 138182  [12-29-99]

299.  Rx 138182  [01-02-00]

300.  Rx 138182  [01-03-00]

301.  Rx 119088, Rx 119089, Rx 119090, and Rx 119091  [05-03-99]

302.  Rx 123689

303.  Rx 126039  [08-03-99]

304.  Rx 126039  [08-10-99]

305.  Rx 128231  [09-02-99]

306.  Rx 128231  [09-05-99]

307.  Rx 128231  [09-08-99]

308.  Rx 129214  [09-14-99]

309.  Rx 129214  [09-23-99]

310.  Rx 131322

311.  Rx 131720

312.  Rx 133429

 

313.  Rx 115374

314.  Rx 115373

315.  Rx 118184

316.  Rx 118186

317.  Rx 121042

318.  Rx 121568

319.  Rx 122869

320.  Rx 127357

321.  Rx 128729

322.  Rx 129915

323.  Rx 130164

324.  Rx 131321

325.  Rx 132420

 

326.  Rx 132718

327.  Rx 135324

328.  Rx 135325

329.  Rx 137810 and Rx 137814  [12-23-99]

330.  Rx 137811 and Rx 137813  [12-23-99]

331.  Rx 140546

332.  Rx 140547

334.  Rx 143275

335.  Rx 143276

336.  Rx 145940

337.  Rx 145941

338.  Rite Aid Customer History Report for Patient #9  [01-01-98 to 04-30-01]

338A.  Therapy Days/Calendar Days Comparison Report for Patient #9  [12-09-98 to 04-13-00]

339.  Rx 106111  [12-09-98]

340.  Rx 106111  [12-13-98]

341.  Rx 106111  [12-16-98]

342.  Rx 106111  [12-20-98]

343.  Rx 106111  [12-24-98]

344.  Rx 106111  [12-28-98]

 

345.  Rx 127465  [08-24-99]

346.  Rx 127465  [00-00-00]

347.  Rx 127465  [09-13-99]

348.  Rx 127465  [09-24-99]

349.  Rx 127465  [10-05-99]

350.  Rx 131899  [10-14-99]

351.  Rx 131899  [10-22-99]

352.  Rx 131899  [11-01-99]

353.  Rx 141264  [01-31-00]

354.  Rx 141264  [02-22-00]

355.  Rx 141264  [03-22-00]

356.  Rx 141264  [04-13-00]

357.  Rite Aid Customer History Report for Patient #10  [03-01-98 to 05-11-00]

357A.  Therapy Days/Calendar Days Comparison Report for Patient #10  [01-08-99 to 10-20-99]

358.  Rx 108422  [01-08-99]

359.  Rx 108422  [01-22-99]

360.  Rx 110954  [02-08-99]

361.  Rx 110954  [02-20-99]

362.  Rx 113367

363.  Rx 122544

364.  Rx 123697

365.  Rx 124468  [07-13-99]

366.  Rx 124468  [07-14-99]

367.  Rx 125703

 

368.  Rx 126533

369.  Rite Aid Printout of Rx 127256

370.  Rx 127663  [08-26-99]

371.  Rx 127663  [08-27-99]

372.  Rx 128548

373.  Rx 129016

374.  Rx 129515

375.  Rx 130141

376.  Rx 130273 and Rx 130274

377.  Rx 131069

378.  Rx 131473

379.  Rx 132488

380.  R.Ph. Linhart handwritten notes for sales of OxyContin to Patient #10

381.  Rx 138885

382.  Indictment of Charles R. Willson, Case No. 2001CR0433B, Stark County Common Pleas Court  [04-10-01]

383.  Judgment Entry, Change of Plea, and Pre-Sentence Investigation.  State of Ohio vs. Charles R. Willson, Case No. 2001CR0433B, Stark County Court of Common Pleas  [05-22-01]

384.  Judgment Entry, Community Control Denied, and Prison Sentence Imposed.  State of Ohio vs. Charles R. Willson, Case No. 2001CR0433B, Stark County Court of Common Pleas  [06-22-01]

385.  Copy of Rules 4729-5-20 and 4729-5-22 of the Ohio Administrative Code

 

 

Respondent's Exhibits

A-M.  Letters of Support from Cathyrn L. Russell [05-02-01]; Bonnie J. Lewis [04-29-01]; Sandra K. Pelley [03-30-01]; Diana Priest, Ron Priest, and Dave Priest [04-05-01]; Charles and Jean Husat [not dated]; Randall E. Davis [not dated]; Andy. Ney and Dotty Ney [03-29-01]; Velma E. Glass [04-27-01]; Sylvia Handy [04-03-01]; Arthur P. Boehm and Rose M. Boehm [not dated]; Don Denny [04-18-01]; Charlene Fields and Lynn E. Fields [01-30-02]; Alice Kerns [01-30-02]

N.  Letter from Chuck Willson [03-26-01]

 

 

FINDINGS OF FACT

 

After having heard the testimony, observed the demeanor of the witnesses, considered the evidence, and weighed the credibility of each, the State Board of Pharmacy finds the follow­ing to be fact:

 

 

(1)  Records of the State Board of Pharmacy indicate that Charles Raymond Willson was originally licensed by the State of Ohio as a Pharmacist on March 26, 1985, pursuant to reciprocity, and that his license to practice pharmacy in Ohio was summarily suspended effective March 13, 2001.  Records further reflect that Charles Raymond Willson was the Responsible Pharmacist at Rite Aid Discount Pharmacy #3167 pursuant to Sections 4729.27 and 4729.55 of the Ohio Revised Code and Rule 4729-5-11 of the Ohio Administrative Code.

 

 

(2)  Charles R. Willson did, from July 5, 2000, through August 1, 2000, knowingly sell a con­trolled substance in an amount less than the bulk amount when the conduct was not in accordance with Chapters 3719., 4729., and 4731. of the Ohio Revised Code, to wit: with­out a prescription and without a legitimate medical purpose, Charles R. Willson sold 160 capsules of Oxazepam 15mg., a Schedule III controlled substance.  Such conduct violates Section 2925.03 of the Ohio Revised Code.

 

 

(3)  Charles R. Willson did, from July 5, 2000, through August 1, 2000, knowingly sell a con­trolled substance in an amount less than the bulk amount when the conduct was not in accordance with Chapters 3719., 4729., and 4731. of the Ohio Revised Code, to wit: with­out a prescription and without a legitimate medical purpose, Charles R. Willson sold 50 tab­lets of Diazepam 10mg., a Schedule III controlled substance.  Such conduct violates Section 2925.03 of the Ohio Revised Code.

 

 

(4)  Charles R. Willson did, on or about August 1, 2000, intentionally make and/or know­ingly possess a false or forged prescription, to wit: Charles R. Willson created false entries on Prescription (Rx) 156572, which had been written for 100 tablets of OxyContin 40mg, in order to cover for his illegal sale of 84 tablets of the drug to an individual other than the actual patient, and he maintained the false prescription on file in the pharmacy to cover for the shortage.  Such conduct violates Section 2925.23(B) of the Ohio Revised Code.

 

 

(5)  Charles R. Willson as the Responsible Pharmacist did, from May 1, 1999, through March 8, 2001, fail to keep records of all controlled substances received, administered, dispensed, sold, or used, to wit: Charles R. Willson failed to account for the following controlled sub­stances at Rite Aid #3167:

 

 

 

Schedule

Drug

Strength

Shortage

 

 

 

II

Adderall

10

348

 

 

 

II

Concerta

36

59

 

 

 

II

OxyContin

10

100

 

 

 

II

OxyContin

20

174

 

 

 

II

OxyContin

40

111

 

 

 

II

oxycodone/apap

5/500

14

 

 

 

II

oxycodone/apap

5/325

684

 

 

 

III

phentermine

30

320

 

 

 

III

phentermine

37.5

6

 

 

 

III

Vicoprofen

7.5/200

1,041

 

 

 

IV

alprazolam

0.25

914

 

 

 

IV

alprazolam

0.5

2,194

 

 

 

IV

alprazolam

1

5,681

 

 

 

IV

alprazolam

2

260

 

 

 

IV

lorazepam

1

3,723

 

 

 

IV

lorazepam

2

1,130

 

 

 

IV

diazepam

2

132

 

 

 

IV

diazepam

5

2,385

 

 

 

IV

diazepam

10

2,514

 

 

 

IV

temazepam

15

4

 

 

 

IV

temazepam

30

58

 

 

 

IV

oxazepam

10

205

 

 

 

IV

oxazepam

15

357

 

 

 

IV

meprobamate

200

117

 

 

 

IV

meprobamate

400

125

 

 

 

Such conduct violates Section 3719.07 of the Ohio Revised Code and Rule 4729-9-14 of the Ohio Administrative Code.

 

 

(6)  Charles R. Willson did, on dates immediately preceding March 8, 2001, knowing that a felony had been committed, fail to report such information to law enforcement authorities, to wit: Charles R. Willson admitted to agents of the Board of Pharmacy that after he had learned that another pharmacist had  trafficked in 84 tablets of OxyContin 40mg, he agreed to aid in concealing the illegal sale by using an undispensed, on file, OxyContin 40mg prescription held for another patient.  Further, Charles R. Willson stated that he and the other pharmacist had agreed to secure the patient's cooperation by committing additional drug trafficking offenses by supplying him with controlled substances (160 capsules of oxazepam 15mg & 50 tablets of diazepam 10mg).  Such conduct violates Section 2921.22 of the Ohio Revised Code.

 

 

(7)  Charles R. Willson as the Responsible Pharmacist did, from January 4, 1999, through February 12, 2001, continuously fail to perform prospective drug utiliza­tion review and patient counseling, to wit: when dispensing medications to patients #1, #2, #3, #4, #5, #6, #7, #8, #9, and #10, pursuant to the prescriptions iterated in this Notice, Charles R. Willson and/or pharmacists under his control failed to re­view the ori­ginal prescription and/or refill information for over-utilization, incorrect drug dosage and duration of drug treatment, and misuse; and Charles R. Willson and/or pharma­cists under his control failed to offer patient counseling.  Such con­duct violates Rules 4729-5-20 and 4729-5-22 of the Ohio Administra­tive Code.

 

 

(8)  Charles R. Willson did, on or about January 26, 2001, and again on February 15, 2001, intentionally create and/or knowingly possess false or forged prescrip­tions, to wit: Charles R. Willson created documents and recorded them at Rite Aid #3167 as the below-listed prescriptions.  These documents purported to be pre­scriptions authorized by a physician, and Charles R. Willson billed them to Medi­caid.  Charles R. Willson admitted to Board of Pharmacy agents that the physician had specifically advised him that she would not author­ize said prescriptions.  How­ever, Charles R. Willson created both documents in order to cover the billing and sale of these over-the-counter substances.

 

 

 

Rx #

Dispensed

Drug

Disp. R.Ph.

Qty.

Doctor

 

 

 

172456

01-26-01

Humulin N 100U/ml

Willson

10 vials

Diglisic

 

 

 

174620

02-15-01

Insulin Syringes U100 1/2mls

Willson

10 syringes

Diglisic

 

 

 

Such conduct violates Section 2925.23(A) of the Ohio Revised Code.

 

 

(9)  Charles R. Willson as the Responsible Pharmacist did, from January 4, 1999, through February 12, 2001, sell controlled substances to patient #1 when not in accordance with Chapters 3719., 4729., and 4731. of the Ohio Revised Code, to wit: Charles R. Willson and others transferred controlled substances during the following instances without having a valid prescription or a legitimate medical purpose:

 

 

 

Rx #

Drug

Strength

Qty

 

 

 

107902

oxycodone/apap

5/325

100

 

 

 

108995

oxycodone/apap

5/325

100

 

 

 

109647

oxycodone/apap

5/325

100

 

 

 

110304

oxycodone/apap

5/325

100

 

 

 

110945

oxycodone/apap

5/325

100

 

 

 

111648

oxycodone/apap

5/325

100

 

 

 

112443

oxycodone/apap

5/325

100

 

 

 

113221

oxycodone/apap

5/325

100

 

 

 

115411

oxycodone/apap

5/325

100

 

 

 

116586

oxycodone/apap

5/325

100

 

 

 

117183

oxycodone/apap

5/325

100

 

 

 

117881

oxycodone/apap

5/325

100

 

 

 

118476

oxycodone/apap

5/325

100

 

 

 

119014

oxycodone/apap

5/325

100

 

 

 

120178

oxycodone/apap

5/325

100

 

 

 

120766

oxycodone/apap

5/325

100

 

 

 

121284

oxycodone/apap

5/325

100

 

 

 

121847

oxycodone/apap

5/325

100

 

 

 

122384

oxycodone/apap

5/325

100

 

 

 

122912

oxycodone/apap

5/325

100

 

 

 

123454

oxycodone/apap

5/325

100

 

 

 

123680

oxycodone/apap

5/325

100

 

 

 

124375

oxycodone/apap

5/325

100

 

 

 

124890

oxycodone/apap

5/325

100

 

 

 

125603

oxycodone/apap

5/325

100

 

 

 

126031

oxycodone/apap

5/325

100

 

 

 

127050

oxycodone/apap

5/325

100

 

 

 

127898

oxycodone/apap

5/325

100

 

 

 

129044

oxycodone/apap

5/325

100

 

 

 

129708

oxycodone/apap

5/325

100

 

 

 

130313

oxycodone/apap

5/325

100

 

 

 

131561

oxycodone/apap

5/325

100

 

 

 

133942

oxycodone/apap

5/325

100

 

 

 

134576

oxycodone/apap

5/325

100

 

 

 

135215

oxycodone/apap

5/325

100

 

 

 

135672

oxycodone/apap

5/325

100

 

 

 

136246

oxycodone/apap

5/325

100

 

 

 

136822

oxycodone/apap

5/325

100

 

 

 

137475

oxycodone/apap

5/325

100

 

 

 

138758

OxyContin

40

34

 

 

 

140060

oxycodone/apap

5/325

100

 

 

 

140297

OxyContin

40

60

 

 

 

140918

oxycodone/apap

5/325

100

 

 

 

141326

OxyContin

40

100

 

 

 

141327

oxycodone/apap

5/325

100

 

 

 

141932

oxycodone/apap

5/325

100

 

 

 

142558

oxycodone/apap

5/325

100

 

 

 

143202

oxycodone/apap

5/325

100

 

 

 

143748

oxycodone/apap

5/325

100

 

 

 

144434

oxycodone/apap

5/325

100

 

 

 

145054

oxycodone/apap

5/325

100

 

 

 

145705

oxycodone/apap

5/325

100

 

 

 

146410

oxycodone/apap

5/325

100

 

 

 

147080

oxycodone/apap

5/325

100

 

 

 

147696

oxycodone/apap

5/325

100

 

 

 

148247

oxycodone/apap

5/325

100

 

 

 

148526

OxyContin

40

60

 

 

 

148837

oxycodone/apap

5/325

100

 

 

 

149416

OxyContin

40

30

 

 

 

149415

oxycodone/apap

5/325

100

 

 

 

150003

oxycodone/apap

5/325

100

 

 

 

150575

oxycodone/apap

5/325

100

 

 

 

151107

oxycodone/apap

5/325

100

 

 

 

151799

oxycodone/apap

5/325

72

 

 

 

152147

oxycodone/apap

5/325

100

 

 

 

152760

oxycodone/apap

5/325

100

 

 

 

153274

oxycodone/apap

5/325

100

 

 

 

154357

oxycodone/apap

5/325

100

 

 

 

154829

oxycodone/apap

5/325

100

 

 

 

155372

oxycodone/apap

5/325

100

 

 

 

158749

oxycodone/apap

5/325

120

 

 

 

159782

oxycodone/apap

5/325

100

 

 

 

160384

oxycodone/apap

5/325

100

 

 

 

161081

oxycodone/apap

5/325

100

 

 

 

162954

oxycodone/apap

5/325

100

 

 

 

163571

oxycodone/apap

5/325

100

 

 

 

164728

oxycodone/apap

5/325

100

 

 

 

165417

oxycodone/apap

5/325

100

 

 

 

166126

oxycodone/apap

5/325

100

 

 

 

166604

oxycodone/apap

5/325

100

 

 

 

167309

oxycodone/apap

5/325

100

 

 

 

167965

oxycodone/apap

5/325

100

 

 

 

168630

oxycodone/apap

5/325

100

 

 

 

169579

oxycodone/apap

5/325

100

 

 

 

172315

oxycodone/apap

5/325

60

 

 

 

172700

oxycodone/apap

5/325

100

 

 

 

173520

oxycodone/apap

5/325

100

 

 

 

174258

oxycodone/apap

5/325

100

 

 

 

Such conduct violates Section 2925.03 of the Ohio Revised Code.

 

 

(10)  Charles R. Willson as the Responsible Pharmacist did, on or about January 4, 1999, through February 12, 2001, intentionally create and/or knowingly possess false or forged prescriptions for patient #1, to wit: Charles R. Willson and others created and possessed on file at the pharmacy the following prescriptions not written for a legiti­mate medical purpose or otherwise approved by an authorized prescriber:

 

 

 

Rx #

Drug

Strength

Qty

 

 

 

107902

oxycodone/apap

5/325

100

 

 

 

108995

oxycodone/apap

5/325

100

 

 

 

109647

oxycodone/apap

5/325

100

 

 

 

110304

oxycodone/apap

5/325

100

 

 

 

110945

oxycodone/apap

5/325

100

 

 

 

111648

oxycodone/apap

5/325

100

 

 

 

112443

oxycodone/apap

5/325

100

 

 

 

113221

oxycodone/apap

5/325

100

 

 

 

115411

oxycodone/apap

5/325

100

 

 

 

116586

oxycodone/apap

5/325

100

 

 

 

117183

oxycodone/apap

5/325

100

 

 

 

117881

oxycodone/apap

5/325

100

 

 

 

118476

oxycodone/apap

5/325

100

 

 

 

119014

oxycodone/apap

5/325

100

 

 

 

120178

oxycodone/apap

5/325

100

 

 

 

120766

oxycodone/apap

5/325

100

 

 

 

121284

oxycodone/apap

5/325

100

 

 

 

121847

oxycodone/apap

5/325

100

 

 

 

122384

oxycodone/apap

5/325

100

 

 

 

122912

oxycodone/apap

5/325

100

 

 

 

123454

oxycodone/apap

5/325

100

 

 

 

123680

oxycodone/apap

5/325

100

 

 

 

124375

oxycodone/apap

5/325

100

 

 

 

124890

oxycodone/apap

5/325

100

 

 

 

125603

oxycodone/apap

5/325

100

 

 

 

126031

oxycodone/apap

5/325

100

 

 

 

127050

oxycodone/apap

5/325

100

 

 

 

127898

oxycodone/apap

5/325

100

 

 

 

129044

oxycodone/apap

5/325

100

 

 

 

129708

oxycodone/apap

5/325

100

 

 

 

130313

oxycodone/apap

5/325

100

 

 

 

131561

oxycodone/apap

5/325

100

 

 

 

133942

oxycodone/apap

5/325

100

 

 

 

134576

oxycodone/apap

5/325

100

 

 

 

135215

oxycodone/apap

5/325

100

 

 

 

135672

oxycodone/apap

5/325

100

 

 

 

136246

oxycodone/apap

5/325

100

 

 

 

136822

oxycodone/apap

5/325

100

 

 

 

137475

oxycodone/apap

5/325

100

 

 

 

138758

OxyContin

40

34

 

 

 

140060

oxycodone/apap

5/325

100

 

 

 

140297

OxyContin

40

60

 

 

 

140918

oxycodone/apap

5/325

100

 

 

 

141326

OxyContin

40

100

 

 

 

141327

oxycodone/apap

5/325

100

 

 

 

141932

oxycodone/apap

5/325

100

 

 

 

142558

oxycodone/apap

5/325

100

 

 

 

143202

oxycodone/apap

5/325

100

 

 

 

143748

oxycodone/apap

5/325

100

 

 

 

144434

oxycodone/apap

5/325

100

 

 

 

145054

oxycodone/apap

5/325

100

 

 

 

145705

oxycodone/apap

5/325

100

 

 

 

146410

oxycodone/apap

5/325

100

 

 

 

147080

oxycodone/apap

5/325

100

 

 

 

147696

oxycodone/apap

5/325

100

 

 

 

148247

oxycodone/apap

5/325

100

 

 

 

148526

OxyContin

40

60

 

 

 

148837

oxycodone/apap

5/325

100

 

 

 

149416

OxyContin

40

30

 

 

 

149415

oxycodone/apap

5/325

100

 

 

 

150003

oxycodone/apap

5/325

100

 

 

 

150575

oxycodone/apap

5/325

100

 

 

 

151107

oxycodone/apap

5/325

100

 

 

 

151799

oxycodone/apap

5/325

72

 

 

 

152147

oxycodone/apap

5/325

100

 

 

 

152760

oxycodone/apap

5/325

100

 

 

 

153274

oxycodone/apap

5/325

100

 

 

 

154357

oxycodone/apap

5/325

100

 

 

 

154829

oxycodone/apap

5/325

100

 

 

 

155372

oxycodone/apap

5/325

100

 

 

 

158749

oxycodone/apap

5/325

120

 

 

 

159782

oxycodone/apap

5/325

100

 

 

 

160384

oxycodone/apap

5/325

100

 

 

 

161081

oxycodone/apap

5/325

100

 

 

 

162954

oxycodone/apap

5/325

100

 

 

 

163571

oxycodone/apap

5/325

100

 

 

 

164728

oxycodone/apap

5/325

100

 

 

 

165417

oxycodone/apap

5/325

100

 

 

 

166126

oxycodone/apap

5/325

100

 

 

 

166604

oxycodone/apap

5/325

100

 

 

 

167309

oxycodone/apap

5/325

100

 

 

 

167965

oxycodone/apap

5/325

100

 

 

 

168630

oxycodone/apap

5/325

100

 

 

 

169579

oxycodone/apap

5/325

100

 

 

 

172315

oxycodone/apap

5/325

60

 

 

 

172700

oxycodone/apap

5/325

100

 

 

 

173520

oxycodone/apap

5/325

100

 

 

 

174258

oxycodone/apap

5/325

100

 

 

 

Such conduct violates Section 2925.23 of the Ohio Revised Code.

 

(11)  Charles R. Willson as the Responsible Pharmacist did, from December 28, 1998, through April 28, 2000, sell controlled substances to patient #2 when not in accordance with Chapters 3719., 4729., and 4731. of the Ohio Revised Code, to wit: Charles R. Willson and others transferred controlled substances during the following instances without having a valid prescription or a legitimate medical purpose:

 

 

 

Rx #

Drug

Strength

Qty

 

 

 

107486

Ambien

10

30

 

 

 

107486

Ambien

10

30

 

 

 

110753

Ambien

10

30

 

 

 

110753

Ambien

10

30

 

 

 

114580

Ambien

10

30

 

 

 

116157

Ambien

10

30

 

 

 

117992

Ambien

10

30

 

 

 

117992

Ambien

10

30

 

 

 

117992

Ambien

10

30

 

 

 

126067

temazepam

30

30

 

 

 

126067

temazepam

30

30

 

 

 

126067

temazepam

30

30

 

 

 

130697

temazepam

30

30

 

 

 

132971

temazepam

30

30

 

 

 

132971

temazepam

30

30

 

 

 

136169

temazepam

30

30

 

 

 

136169

temazepam

30

30

 

 

 

139260

temazepam

30

30

 

 

 

139260

temazepam

30

30

 

 

 

139260

temazepam

30

30

 

 

 

144806

temazepam

30

30

 

 

 

144806

temazepam

30

30

 

 

 

149281

temazepam

30

30

 

 

 

Such conduct violates Section 2925.03 of the Ohio Revised Code.

 

(12)  Charles R. Willson as the Responsible Pharmacist did, on or about December 28, 1998, through April 28, 2000, intentionally create and/or knowingly possess false or forged pre­scriptions for patient #2, to wit: Charles R. Willson and others created and possessed on file at the pharmacy the following prescriptions not written for a legi­timate medical purpose or otherwise approved by an authorized prescriber:

 

 

 

Rx #

Drug

Strength

Qty

 

 

 

107486

Ambien

10

30

 

 

 

107486

Ambien

10

30

 

 

 

110753

Ambien

10

30

 

 

 

110753

Ambien

10

30

 

 

 

114580

Ambien

10

30

 

 

 

116157

Ambien

10

30

 

 

 

117992

Ambien

10

30

 

 

 

117992

Ambien

10

30

 

 

 

117992

Ambien

10

30

 

 

 

126067

temazepam

30

30

 

 

 

126067

temazepam

30

30

 

 

 

126067

temazepam

30

30

 

 

 

130697

temazepam

30

30

 

 

 

132971

temazepam

30

30

 

 

 

132971

temazepam

30

30

 

 

 

136169

temazepam

30

30

 

 

 

136169

temazepam

30

30

 

 

 

139260

temazepam

30

30

 

 

 

139260

temazepam

30

30

 

 

 

139260

temazepam

30

30

 

 

 

144806

temazepam

30

30

 

 

 

144806

temazepam

30

30

 

 

 

149281

temazepam

30

30

 

 

 

Such conduct violates Section 2925.23 of the Ohio Revised Code.

 

 

(13)  Charles R. Willson as the Responsible Pharmacist did, from March 2, 1999, through October 8, 1999, sell controlled substances to patient #3 when not in accordance with Chapters 3719., 4729., and 4731. of the Ohio Revised Code, to wit: Charles R. Willson and others sold controlled substances during the following instances without having a valid prescription or a legitimate medical purpose:

 

 

 

Rx #

Drug

Strength

Qty

 

 

 

115068

diazepam

5

90

 

 

 

115068

diazepam

5

90

 

 

 

115068

diazepam

5

90

 

 

 

117850

diazepam

10

3

 

 

 

113313

lorazepam

2

90

 

 

 

113313

lorazepam

2

90

 

 

 

117852

lorazepam

1

30

 

 

 

118466

lorazepam

2

14

 

 

 

118466

lorazepam

2

14

 

 

 

119036

lorazepam

2

60

 

 

 

119976

lorazepam

2

10

 

 

 

119036

lorazepam

2

60

 

 

 

119036

lorazepam

2

60

 

 

 

119036

lorazepam

2

60

 

 

 

119036

lorazepam

2

60

 

 

 

125963

lorazepam

2

60

 

 

 

125963

lorazepam

2

60

 

 

 

125963

lorazepam

2

10

 

 

 

127996

lorazepam

2

15

 

 

 

127996

lorazepam

2

15

 

 

 

129685

lorazepam

2

50

 

 

 

131447

lorazepam

2

15

 

 

 

Such conduct violates Section 2925.03 of the Ohio Revised Code.

 

(14)  Charles R. Willson as the Responsible Pharmacist did, on or about March 2, 1999, through October 8, 1999, intentionally create and/or knowingly possess false or forged prescriptions for patient #3, to wit Charles R. Willson and others created and possessed on file at the pharmacy the following prescriptions not written for a legiti­mate medical purpose or otherwise approved by an authorized prescriber:

 

 

 

Rx #

Drug

Strength

Qty

 

 

 

115068

diazepam

5

90

 

 

 

115068

diazepam

5

90

 

 

 

115068

diazepam

5

90

 

 

 

117850

diazepam

10

3

 

 

 

113313

lorazepam

2

90

 

 

 

113313

lorazepam

2

90

 

 

 

117852

lorazepam

1

30

 

 

 

118466

lorazepam

2

14

 

 

 

118466

lorazepam

2

14

 

 

 

119036

lorazepam

2

60

 

 

 

119976

lorazepam

2

10

 

 

 

119036

lorazepam

2

60

 

 

 

119036

lorazepam

2

60

 

 

 

119036

lorazepam

2

60

 

 

 

119036

lorazepam

2

60

 

 

 

125963

lorazepam

2

60

 

 

 

125963

lorazepam

2

60

 

 

 

125963

lorazepam

2

10

 

 

 

127996

lorazepam

2

15

 

 

 

127996

lorazepam

2

15

 

 

 

129685

lorazepam

2

50

 

 

 

131447

lorazepam

2

15

 

 

 

Such conduct violates Section 2925.23 of the Ohio Revised Code.

 

 

(15)  Charles R. Willson as the Responsible Pharmacist did, from February 12, 1998, through December 6, 1998, sell controlled substances to patient #4 when not in accor­dance with Chapters 3719., 4729., and 4731. of the Ohio Revised Code, to wit: Charles R. Willson and others sold controlled substances during the following instances without hav­ing a valid prescription or a legitimate medical purpose:

 

 

 

Rx #

Drug

Strength

Qty

 

 

 

82946

Ambien

10

30

 

 

 

84341

Ambien

10

30

 

 

 

86049

Ambien

10

30

 

 

 

87555

Ambien

10

35

 

 

 

89483

Ambien

10

20

 

 

 

91136

Ambien

10

35

 

 

 

91136

Ambien

10

35

 

 

 

94234

Ambien

10

30

 

 

 

95990

Ambien

10

30

 

 

 

98345

Ambien

10

21

 

 

 

99663

Ambien

10

35

 

 

 

99663

Ambien

10

14

 

 

 

101837

Ambien

10

30

 

 

 

103319

Ambien

10

30

 

 

 

103697

Ambien

10

20

 

 

 

104432

Ambien

10

35

 

 

 

105076

Ambien

10

30

 

 

 

104432

Ambien

10

35

 

 

 

104432

Ambien

10

35

 

 

 

84342

OxyContin

40

100

 

 

 

84681

OxyContin

40

20

 

 

 

85607

OxyContin

40

20

 

 

 

85671

OxyContin

40

100

 

 

 

86048

OxyContin

40

20

 

 

 

87336

OxyContin

40

100

 

 

 

87556

OxyContin

40

20

 

 

 

88253

OxyContin

40

20

 

 

 

97257

OxyContin

40

60

 

 

 

98496

OxyContin

40

60

 

 

 

100689

OxyContin

40

60

 

 

 

102062

OxyContin

40

60

 

 

 

102546

OxyContin

40

60

 

 

 

103038

OxyContin

40

90

 

 

 

103803

OxyContin

20

10

 

 

 

104766

OxyContin

40

60

 

 

 

Such conduct violates Section 2925.03 of the Ohio Revised Code.

 

 

(16) Charles R. Willson as the Responsible Pharmacist did, on or about February 12, 1998, through December 6, 1998, intentionally create and/or knowingly possess false or forged prescriptions for patient #4, to wit: Charles R. Willson and others created and possessed on file at the pharmacy the following prescriptions not written for a legitimate medical purpose or otherwise approved by an authorized prescriber:

 

 

 

Rx #

Drug

Strength

Qty

 

 

 

82946

Ambien

10

30

 

 

 

84341

Ambien

10

30

 

 

 

86049

Ambien

10

30

 

 

 

87555

Ambien

10

35

 

 

 

89483

Ambien

10

20

 

 

 

91136

Ambien

10

35

 

 

 

91136

Ambien

10

35

 

 

 

94234

Ambien

10

30

 

 

 

95990

Ambien

10

30

 

 

 

98345

Ambien

10

21

 

 

 

99663

Ambien

10

35

 

 

 

99663

Ambien

10

14

 

 

 

101837

Ambien

10

30

 

 

 

103319

Ambien

10

30

 

 

 

103697

Ambien

10

20

 

 

 

104432

Ambien

10

35

 

 

 

105076

Ambien

10

30

 

 

 

104432

Ambien

10

35

 

 

 

104432

Ambien

10

35

 

 

 

84342

OxyContin

40

100

 

 

 

84681

OxyContin

40

20

 

 

 

85607

OxyContin

40

20

 

 

 

85671

OxyContin

40

100

 

 

 

86048

OxyContin

40

20

 

 

 

87336

OxyContin

40

100

 

 

 

87556

OxyContin

40

20

 

 

 

88253

OxyContin

40

20

 

 

 

97257

OxyContin

40

60

 

 

 

98496

OxyContin

40

60

 

 

 

100689

OxyContin

40

60

 

 

 

102062

OxyContin

40

60

 

 

 

102546

OxyContin

40

60

 

 

 

103038

OxyContin

40

90

 

 

 

103803

OxyContin

20

10

 

 

 

104766

OxyContin

40

60

 

 

 

Such conduct violates Section 2925.23 of the Ohio Revised Code.

 

(17)  Charles R. Willson as the Responsible Pharmacist did, from November 10, 2000 through February 10, 2001, sell controlled substances to patient #5 when not in accor­dance with Chapters 3719., 4729., and 4731. of the Ohio Revised Code, to wit: Charles R. Willson and others sold controlled substances during the following instances with­out having a valid prescription or a legitimate medical purpose:

 

 

 

Rx #

Drug

Strength

Qty

 

 

 

165203

hydrocodone/apap

5/500

50

 

 

 

165203

hydrocodone/apap

5/500

50

 

 

 

165203

hydrocodone/apap

5/500

50

 

 

 

168031

hydrocodone/apap

5/500

50

 

 

 

168626

hydrocodone/apap

5/500

100

 

 

 

168626

hydrocodone/apap

5/500

30

 

 

 

168626

hydrocodone/apap

5/500

30

 

 

 

169313

hydrocodone/apap

5/500

40

 

 

 

169313

hydrocodone/apap

5/500

40

 

 

 

169313

hydrocodone/apap

5/500

40

 

 

 

169313

hydrocodone/apap

5/500

30

 

 

 

171918

hydrocodone/apap

5/500

100

 

 

 

171918

hydrocodone/apap

5/500

30

 

 

 

171918

hydrocodone/apap

5/500

40

 

 

 

171918

hydrocodone/apap

5/500

30

 

 

 

Such conduct violates Section 2925.03 of the Ohio Revised Code.

 

 

(17)(A)  Charles R. Willson as the Responsible Pharmacist did, from July 7, 1999, through February 10, 2001, sell dangerous drugs to patient #5 when not in accor­dance with Chap­ters 3719., 4729., and 4731. of the Ohio Revised Code, to wit: Charles R. Willson and others transferred controlled substances during the follow­ing instances without having a valid prescription or a legitimate medical purpose:

 

 

 

Rx #

Drug

Strength

Qty

 

 

 

124089

carisoprodol

350

100

 

 

 

124089

carisoprodol

350

100

 

 

 

125089

carisoprodol

350

50

 

 

 

125089

carisoprodol

350

50

 

 

 

125089

carisoprodol

350

50

 

 

 

125089

carisoprodol

350

50

 

 

 

125089

carisoprodol

350

50

 

 

 

125089

carisoprodol

350

50

 

 

 

129875

carisoprodol

350

100

 

 

 

129875

carisoprodol

350

100

 

 

 

139324

carisoprodol

350

50

 

 

 

139324

carisoprodol

350

50

 

 

 

139324

carisoprodol

350

50

 

 

 

141487

carisoprodol

350

50

 

 

 

141487

carisoprodol

350

50

 

 

 

141487

carisoprodol

350

50

 

 

 

145317

carisoprodol

350

50

 

 

 

145317

carisoprodol

350

50

 

 

 

145317

carisoprodol

350

50

 

 

 

145317

carisoprodol

350

50

 

 

 

145317

carisoprodol

350

50

 

 

 

149465

carisoprodol

350

50

 

 

 

149465

carisoprodol

350

50

 

 

 

151803

carisoprodol

350

50

 

 

 

152940

carisoprodol

350

50

 

 

 

152940

carisoprodol

350

50

 

 

 

154989

carisoprodol

350

50

 

 

 

154989

carisoprodol

350

50

 

 

 

154989

carisoprodol

350

50

 

 

 

154989

carisoprodol

350

50

 

 

 

168024

carisoprodol

350

50

 

 

 

168627

carisoprodol

350

100

 

 

 

168627

carisoprodol

350

30

 

 

 

168627

carisoprodol

350

30

 

 

 

168627

carisoprodol

350

40

 

 

 

171917

carisoprodol

350

100

 

 

 

173117

carisoprodol

350

30

 

 

 

173117

carisoprodol

350

40

 

 

 

173117

carisoprodol

350

30

 

 

 

Such conduct violates Section 4729.51(C) of the Ohio Revised Code.

 

 

(18)  Charles R. Willson as the Responsible Pharmacist did, on or about July 7, 1999, through February 10, 2001, intentionally create and/or knowingly possess false or forged prescriptions for patient #5, to wit: Charles R. Willson and others created and possessed on file at the pharmacy the following prescriptions not written for a legitimate medical purpose or otherwise approved by an authorized prescriber:

 

 

 

Rx #

Drug

Strength

Qty

 

 

 

124089

carisoprodol

350

100

 

 

 

124089

carisoprodol

350

100

 

 

 

125089

carisoprodol

350

50

 

 

 

125089

carisoprodol

350

50

 

 

 

125089

carisoprodol

350

50

 

 

 

125089

carisoprodol

350

50

 

 

 

125089

carisoprodol

350

50

 

 

 

125089

carisoprodol

350

50

 

 

 

129875

carisoprodol

350

100

 

 

 

129875

carisoprodol

350

100

 

 

 

139324

carisoprodol

350

50

 

 

 

139324

carisoprodol

350

50

 

 

 

139324

carisoprodol

350

50

 

 

 

141487

carisoprodol

350

50

 

 

 

141487

carisoprodol

350

50

 

 

 

141487

carisoprodol

350

50

 

 

 

145317

carisoprodol

350

50

 

 

 

145317

carisoprodol

350

50